EmCell Cell Therapy Center
EmCell Cell Therapy Center
Ucrânia, Quieve
| Ucrânia | Turquia | Áustria | |
| Terapia com células estaminais para ELA (esclerose lateral amiotrófica) | de $25,000 | de $30,000 | de $60,000 |
| Terapia com Células Estaminais | de $2,227 | de $4,675 | de $8,500 |
| Plasmaférese | de $700 | de $1,200 | de $2,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Esclerose lateral amiotrófica. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Esclerose lateral amiotrófica e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Esclerose lateral amiotrófica.
Andrologista-chefe em Kiev com mais de 22 anos de experiência – o Dr. Miroshnykov dirige a clínica Renaissance Technology.
Especialista no diagnóstico e tratamento de doenças neurológicas, com foco no atendimento de adultos no Impuls Medical Center.
Ukraine offers standard pharmacological management alongside specialized fetal and adult stem cell therapies for ALS. Treatment focuses on slowing progression with medications like Riluzole or Edaravone. Specialized clinics in Kyiv utilize mesenchymal and fetal stem cells to support motor neuron function and reduce inflammation.
Bookimed Expert Insight: Kyiv serves as a primary hub for regenerative neurology. EmCell Cell Therapy Center reports serving 600 patients annually with over 30 years of history. This high volume often leads to more refined delivery protocols for intrathecal and intravenous cell administration. Patients should look for ISO-certified facilities like Good Cells Clinic for standardized lab safety.
Patient Consensus: Patients highlight that the medical teams in Kyiv are very communicative and supportive. Many emphasize that having a dedicated coordinator makes the logistics of long-term therapy much easier to manage.
Clinical reports from Ukrainian centers indicate that stem-cell therapy helps stabilize ALS symptoms and slow progression. While not a cure, treatments aim to improve muscle flexibility and respiratory stability. Patients often report reduced muscle twitching and improved swallowing clarity for up to 6 months.
Bookimed Expert Insight: Ukraine offers unique access to fetal stem cell protocols due to specific local regulations. EmCell Cell Therapy Center has focused on this specialized field for over 30 years. Data suggests early-stage intervention yields the most consistent stabilization compared to advanced cases.
Patient Consensus: Patients note that treatment focuses on maintaining current strength rather than regenerating lost muscle. Many emphasize that while it is not a reversal, the temporary stability provides a vital window of improved daily comfort.
Kyiv is the primary hub for specialized Amyotrophic Lateral Sclerosis (ALS) treatment in Ukraine. Leading centers like EmCell and Good Cells focus on regenerative medicine and stem cell therapies. These programs aim to slow disease progression and enhance daily motor function for patients.
Bookimed Expert Insight: Ukrainian clinics show a strong concentration of expertise in cell-based therapies for neurology. EmCell alone treats 600 patients annually and pioneered clinical applications in this field. Facilities like Renaissannce Technology now offer online consultations to review scans before patients travel.
Patient Consensus: Patients note that specialized care is increasingly concentrated in Kyiv and western regions like Lviv. Many emphasize that while regenerative therapies are available, early coordination is essential due to current infrastructure challenges.
Ukrainian clinics must hold a Ministry of Health license and ISO 9001:2015 certification for quality management. Facilities providing stem cell therapy for ALS should operate under Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) standards to ensure cellular product safety and sterility.
Bookimed Expert Insight: Ukraine remains a high-volume destination with over 3,700 requests served through our platform. While EmCell and Good Cells Clinic process 300 to 600 patients annually, verify if the facility uses specialized protocols. For instance, EmCell focuses on fetal stem cells while Good Cells utilizes ISO-certified standards for umbilical and adipose tissue.
Patient Consensus: Patients emphasize the need for third-party cell analysis reports and HLA matching before starting therapy. They also recommend securing medical evacuation insurance and verifying if the clinic provides backup power systems during local infrastructure blackouts.
ALS evaluation and therapy in Ukraine typically require a stay of 5 to 7 days. This timeframe allows for diagnostic confirmation, laboratory preparation of stem cells, and post-procedure observation. Patients seeking intensive physical rehabilitation alongside therapy should plan for a stay of 13 to 14 days.
Bookimed Expert Insight: While most clinics suggest a 1-week stay, volume data shows centers like EmCell treat 600 patients annually. This high throughput often means diagnostics and fetal stem cell preparation are highly synchronized. A 5-day stay is often sufficient for standard cases, but checking for ISO-certified facilities like Good Cells Clinic ensures standardized laboratory protocols during your visit.
Patient Consensus: Patients note it is important to consult a local neurologist before traveling, as long-distance trips can be physically taxing. Many suggest staying at least one full week to ensure adequate rest between diagnostic tests and injections.